| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |